Cellosaurus A-431 (CVCL_0037)

Cell line name A-431
Synonyms A431; A431/P
Accession CVCL_0037
Resource Identification Initiative To cite this cell line use: A-431 (RRID:CVCL_0037)
Comments Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
Doubling time: ~80-100 hours (DSMZ).
Microsatellite instability: Stable (MSS) (Sanger).
Omics: Cell surface proteome.
Omics: Deep antibody staining analysis.
Omics: Deep exome analysis.
Omics: Deep phosphoproteome analysis.
Omics: Deep proteome analysis.
Omics: Deep RNAseq analysis.
Omics: DNA methylation analysis.
Omics: SNP array analysis.
Omics: Transcriptome analysis.
Disease Vulvar squamous cell carcinoma (NCIt: C4052)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Children: CVCL_QX11 (A431 siYAP); CVCL_QX12 (A431 YAP-5SA); CVCL_EQ67 (A431-PR); CVCL_GY97 (A431/CDDP1); CVCL_GY98 (A431/CDDP2); CVCL_4V41 (A431/TPT); CVCL_3485 (A431NS)
Sex of cell Female
Category Cancer cell line
STR profile Source(s): AddexBio; ATCC; CLS; Cosmic-CLP; DSMZ; JCRB; KCLB; PubMed=11416159; PubMed=25877200; RCB; TKG

Markers:
AmelogeninX (ATCC; CLS; Cosmic-CLP; DSMZ; JCRB; KCLB; PubMed=11416159; PubMed=25877200; RCB; TKG)
X,Y (AddexBio)
CSF1PO11,12
D13S3179,13
D16S53912,14
D18S5113,17
D21S1128,30 (CLS; PubMed=11416159)
28 (PubMed=25877200)
D3S135814
D5S81811,13 (AddexBio)
12,13 (ATCC; CLS; Cosmic-CLP; DSMZ; JCRB; KCLB; PubMed=11416159; PubMed=25877200; RCB; TKG)
D7S82010
D8S117913
FGA20
Penta D9,11 (CLS)
11 (PubMed=25877200)
Penta E12,13
TH019
TPOX11
vWA15,17
Web pages https://en.wikipedia.org/wiki/A431_cells
http://www.cells-talk.com/index.php/page/copelibrary?key=A431
http://www.proteinatlas.org/learn/cellines
http://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/a431/a431cells.html
http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/a/cell-lines-detail-78.html
Publications

PubMed=4357758; DOI=10.1093/jnci/51.5.1417
Giard D.J., Aaronson S.A., Todaro G.J., Arnstein P., Kersey J.H., Dosik H., Parks W.P.
In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors.
J. Natl. Cancer Inst. 51:1417-1423(1973)

PubMed=6092175; DOI=10.1016/0303-7207(84)90053-4
Gamou S., Kim Y.S., Shimizu N.
Different responses to EGF in two human carcinoma cell lines, A431 and UCVA-1, possessing high numbers of EGF receptors.
Mol. Cell. Endocrinol. 37:205-213(1984)

PubMed=6500159; DOI=10.1159/000163283
Gershwin M.E., Lentz D., Owens R.B.
Relationship between karyotype of tissue culture lines and tumorigenicity in nude mice.
Exp. Cell Biol. 52:361-370(1984)

PubMed=2990217
Yee C., Krishnan-Hewlett I., Baker C.C., Schlegel R., Howley P.M.
Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines.
Am. J. Pathol. 119:361-366(1985)

PubMed=2758419
Pekkola-Heino K., Kulmala J., Grenman S.E., Carey T.E., Grenman R.
Radiation response of vulvar squamous cell carcinoma (UM-SCV-1A, UM-SCV-1B, UM-SCV-2, and A-431) cells in vitro.
Cancer Res. 49:4876-4878(1989)

PubMed=9290701; DOI=10.1002/(SICI)1098-2744(199708)19:4<243::AID-MC5>3.0.CO;2-D
Jia L.-Q., Osada M., Ishioka C., Gamo M., Ikawa S., Suzuki T., Shimodaira H., Niitani T., Kudo T., Akiyama M., Kimura N., Matsuo M., Mizusawa H., Tanaka N., Koyama H., Namba M., Kanamaru R., Kuroki T.
Screening the p53 status of human cell lines using a yeast functional assay.
Mol. Carcinog. 19:243-253(1997)

PubMed=17178626; DOI=10.1080/09553000600969812
Kurvinen K., Rantanen V., Syrjanen S., Johansson B.
Radiation-induced effects on telomerase in gynecological cancer cell lines with different radiosensitivity and repair capacity.
Int. J. Radiat. Biol. 82:859-867(2006)

PubMed=22108792; DOI=10.1038/msb.2011.84
Munoz J., Low T.Y., Kok Y.J., Chin A., Frese C.K., Ding V., Choo A., Heck A.J.R.
The quantitative proteomes of human-induced pluripotent stem cells and embryonic stem cells.
Mol. Syst. Biol. 7:550-550(2011)

PubMed=24804581; DOI=10.1021/cb500116c
Giansanti P., Preisinger C., Huber K.V.M., Gridling M., Superti-Furga G., Bennett K.L., Heck A.J.R.
Evaluating the promiscuous nature of tyrosine kinase inhibitors assessed in A431 epidermoid carcinoma cells by both chemical- and phosphoproteomics.
ACS Chem. Biol. 9:1490-1498(2014)

PubMed=25485619; DOI=10.1038/nbt.3080
Klijn C., Durinck S., Stawiski E.W., Haverty P.M., Jiang Z., Liu H., Degenhardt J., Mayba O., Gnad F., Liu J., Pau G., Reeder J., Cao Y., Mukhyala K., Selvaraj S.K., Yu M., Zynda G.J., Brauer M.J., Wu T.D., Gentleman R.C., Manning G., Yauch R.L., Bourgon R., Stokoe D., Modrusan Z., Neve R.M., de Sauvage F.J., Settleman J., Seshagiri S., Zhang Z.
A comprehensive transcriptional portrait of human cancer cell lines.
Nat. Biotechnol. 33:306-312(2015)

PubMed=25894527; DOI=10.1371/journal.pone.0121314
Bausch-Fluck D., Hofmann A., Bock T., Frei A.P., Cerciello F., Jacobs A., Moest H., Omasits U., Gundry R.L., Yoon C., Schiess R., Schmidt A., Mirkowska P., Hartlova A., Van Eyk J.E., Bourquin J.-P., Aebersold R., Boheler K.R., Zandstra P., Wollscheid B.
A mass spectrometric-derived cell surface protein atlas.
PLoS ONE 10:E0121314-E0121314(2015)

PubMed=26989177; DOI=10.1242/dev.133728
Elbediwy A., Vincent-Mistiaen Z.I., Spencer-Dene B., Stone R.K., Boeing S., Wculek S.K., Cordero J., Tan E.H., Ridgway R., Brunton V.G., Sahai E., Gerhardt H., Behrens A., Malanchi I., Sansom O.J., Thompson B.J.
Integrin signalling regulates YAP and TAZ to control skin homeostasis.
Development 143:1674-1687(2016)

PubMed=27397505; DOI=10.1016/j.cell.2016.06.017
Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X., Egan R.K., Liu Q., Mironenko T., Mitropoulos X., Richardson L., Wang J., Zhang T., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
A landscape of pharmacogenomic interactions in cancer.
Cell 166:740-754(2016)

Cross-references
Cell line collections AddexBio; C0012001/22
ATCC; CRL-1555
ATCC; CRL-7907 - Discontinued
BCRC; 60161
BCRJ; 0032
CLS; 300112/p753_A-431
DSMZ; ACC-91
ECACC; 85090402
IFO; IFO50411
IZSLER; BS TCL 161
JCRB; JCRB0004
JCRB; JCRB9009
KCB; KCB 200651YJ
KCLB; 21555
KCLB; 80005
NCBI_Iran; C204
RCB; RCB0202
RCB; RCB1872
TKG; TKG 0182
Cell line databases/resources CLDB; cl155
CLDB; cl156
CLDB; cl157
CLDB; cl159
CLDB; cl160
CLDB; cl161
CCRID; 3111C0001CCC000092
CCRID; 3131C0001000700079
CCRID; 3142C0001000000103
Cosmic-CLP; 910925
GDSC; 910925
LINCS_LDP; LCL-1404
Lonza; 814
TOKU-E; 476
Ontologies BTO; BTO:0000017
CLO; CLO_0001591
CLO; CLO_0001592
CLO; CLO_0050011
CLO; CLO_0050012
EFO; EFO_0006268
MCCL; MCC:0000025
Biological sample resources BioSample; SAMN01821614
BioSample; SAMN01821671
BioSample; SAMN01821724
BioSample; SAMN03472220
Chemistry resources ChEMBL-Cells; CHEMBL3307523
ChEMBL-Targets; CHEMBL614069
ChEMBL-Targets; CHEMBL1075390
Gene expression databases GEO; GSM183432
GEO; GSM183433
GEO; GSM827302
GEO; GSM1374384
GEO; GSM1669586
GEO; GSM2112551
GEO; GSM2112555
Other Wikidata; Q4649310
Polymorphism and mutation databases Cosmic; 688038
Cosmic; 735609
Cosmic; 755305
Cosmic; 876559
Cosmic; 897743
Cosmic; 910564
Cosmic; 910925
Cosmic; 974317
Cosmic; 1071898
Cosmic; 1176624
Cosmic; 1351516
Cosmic; 1477434
Cosmic; 1945879
Cosmic; 1995334
Cosmic; 2131571
Cosmic; 2301592
Proteomic databases PRIDE; PXD000589
PRIDE; PXD000681